Mayo Clinic Proceedings Home

Nerve Glucose, Sorbitol, Fructose, and myo-Inositol at Various Times After Feeding in Streptozotocin-Induced Diabetes in Rats

      Because fasting nerve myo-inositol (myo-Ins) is not decreased in patients with diabetes treated conventionally, in whom neuropathy may develop or may have already developed, it seems unlikely that myo-Ins is the metabolic abnormality that initiates diabetic neuropathy, if nerve myo-Ins is not spuriously high during fasting. At 6 weeks after induction of diabetes with streptozotocin in Sprague-Dawley rats, we found that endoneurial glucose, sorbitol, and fructose were substantially increased and myo-Ins was decreased, as reported by others. By use of multiple linear regression to assess the effect of disease condition, time after feeding (1.5, 4, and 20 hours), and duration of diabetes (1,2,6, and 12 weeks) on nerve sugars and alcohol sugars, for nerve glucose, sorbitol, and fructose only disease condition was a statistically significant factor. For nerve myo-Ins, disease group (control or diabetic rats) (P = 0.08), duration of diabetes (P = 0.02), time after feeding (P<0.001), duration × time (P = 0.01), group × duration (P = 0.03), and group × time (P = 0.05) were significant variables. Because nerve myo-Ins was lower at 20 hours than at 1.5 or 4 hours after feeding, for all durations of diabetes, one can infer that in human nerve the lowest nerve myo-Ins, not high values, occurs in the fasting state. Therefore, one would not expect to find lower nerve myo-Ins levels in human diabetics at times other than the fasting condition.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Greene DA
        • Lattimer SA
        Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve.
        J Clin Invest. 1982; 70: 1009-1018
        • Greene DA
        • Yagihashi S
        • Lattimer SA
        • Sima AAF
        Nerve NA+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat.
        Am J Physiol. 1984; 247: E534-E539
        • Greene DA
        • Lattimer S
        • Ulbrecht J
        • Carroll P
        Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy.
        Diabetes Care. 1985; 8: 290-299
        • Sima AAF
        • Lattimer SA
        • Yagihashi S
        • Greene DA
        Axo-glial dysjunction: a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.
        J Clin Invest. 1986; 77: 474-484
        • Greene DA
        • Bril V
        • Lattimer SA
        • Sima AAF
        Correction of myo-inositol depletion in diabetic human sural nerve by treatment with an aldose reductase inhibitor (abstract).
        Diabetes. 1987; 36: 86A
        • Stewart MA
        • Kurien MM
        • Sherman WR
        • Cotlier EV
        Inositol changes in nerve and lens of galactose fed rats.
        J Neurochem. 1968; 15: 941-946
        • Ward JD
        • Baker RWR
        • Davis BH
        Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissue.
        Diabetes. 1972; 21: 1173-1178
        • Greene DA
        • De Jesus Jr, PV
        • Winegrad AI
        Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
        J Clin Invest. 1975; 55: 1326-1336
        • Dyck PJ
        • Sherman WR
        • Hallcher LM
        • Service FJ
        • O'Brien PC
        • Grina LA
        • Palumbo PJ
        • Swanson CJ
        Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
        Ann Neurol. 1980; 8: 590-596
        • Dyck PJ
        • Zimmerman BR
        • Vilen TH
        • Minnerath SR
        • Karnes JL
        • Yao JK
        • Poduslo JF
        Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
        N Engl J Med. 1988; 319: 542-548
        • Hale PJ
        • Nattrass M
        • Silverman SH
        • Sennit C
        • Perkins CM
        • Uden A
        • Sundkvist G
        Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients.
        Diabetologia. 1987; 30: 464-467
        • Dyck PJ
        • Ellefson RD
        • Lais AC
        • Smith RC
        • Taylor WF
        • Van Dyke RA
        Histologic and lipid studies of sural nerves in inherited hypertrophic neuropathy: preliminary report of a lipid abnormality in nerve and liver in Dejerine-Sottas disease.
        Mayo Clin Proc. 1970; 45: 286-327
        • Poduslo JF
        Glycoproteins of the peripheral nervous system.
        in: Dyck PJ Thomas PK Lambert EH Bunge R Second edition. Peripheral Neuropathy. Vol 1. WB Saunders Company, Philadelphia1984: 494-509
        • Lowry OH
        • Rosebrough NJ
        • Farr AL
        • Randall RJ
        Protein measurement with the Folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • Hess HH
        • Lewin E
        Microassay of biochemical structural components in nervous tissue—II.
        J Neurochem. 1965; 12: 205-211
        • Laine RA
        • Sweeley CC
        Analysis of trimethylsilyl O-methyloximes of carbohydrates by combined gas-liquid chromatography-mass spectrometry.
        Anal Biochem. 1971; 43: 533-538
        • Daughaday WH
        • Larner J
        • Houghton E
        The renal excretion of inositol in normal and diabetic human beings.
        J Clin Invest. 1954; 33: 326-332
        • Pirie A
        • van Heyningen R
        The effect of diabetes on the content of sorbitol, glucose, fructose and inositol in the human lens.
        Exp Eye Res. 1964; 3: 124-131
        • Low PC
        • Tuck RR
        • Dyck PJ
        • Schmelzer JD
        • Yao JK
        Prevention of some electrophysiological and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy.
        Proc Natl Acad Sci U S A. 1984; 81: 6894-6898